Clinical Trial Update: PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Progestin-primed Ovarian Stimulation (PPOS) protocol to a GnRH antagonist protocol in expected normal responders undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH antagonist protocol (Gonadotropin-releasing hormone antagonist protocol)
• Progestin-primed Ovarian Stimulation (PPOS) protocol

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: PPOS, GnRH Antagonist | Phase 3 | Status: COMPLETED